Skip to main content
. 2021 Jun 15;10(7):19. doi: 10.1167/tvst.10.7.19

Table 1.

Outline of the In Vivo Study Design

Study Study Size, Delivery Injection Volume Dose* Study Duration PK Timepoints
Number Species Route (Concentration) (mg/Eye) (Weeks) After the Dose
1 n = 10 male NZW rabbits IVT SC 0.025 mL (4 mg/mL) 0.1 mL (10 mg/mL) 1 1 1 0.08, 6, 24, 72, and 168 hours
2 n = 14 male DB rabbits SC 0.1 mL (40 mg/mL) 4 13 2, 4, 8, 15, 29, 61, and 91days
3 n = 14 male DB rabbits SC 0.1 mL (1 mg/mL) 0.1 mL (0.3 mg/mL) 0.1 0.03 10 2, 8, 15, 31, 45, 61, and 66 (±1) days

NZW, New Zealand White; DB, Dutch Belted.

*

Both eyes of each animal were dosed. All animals were free of ophthalmologic abnormalities before test article administration, assessed by a board-certified veterinary ophthalmologist using a slit lamp biomicroscope and an indirect ophthalmoscope.